Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.405
-0.055 (-1.59%)
Dec 3, 2024, 12:06 PM EST - Market open
Arbutus Biopharma Employees
Arbutus Biopharma had 73 employees as of December 31, 2023. The number of employees decreased by 25 or -25.51% compared to the previous year.
Employees
73
Change (1Y)
-25
Growth (1Y)
-25.51%
Revenue / Employee
$92,356
Profits / Employee
-$1,050,685
Market Cap
645.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InnovAge Holding | 2,350 |
CureVac | 1,172 |
Simulations Plus | 247 |
Omeros | 198 |
Monte Rosa Therapeutics | 133 |
Stoke Therapeutics | 110 |
Taysha Gene Therapies | 52 |
Tourmaline Bio | 44 |
ABUS News
- 7 days ago - Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat - GlobeNewsWire
- 18 days ago - Arbutus' Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon - GlobeNewsWire
- 19 days ago - Arbutus to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 26 days ago - Arbutus Biopharma Corporation (ABUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 7 weeks ago - Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meeting® 2024 - GlobeNewsWire
- 3 months ago - Arbutus to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Arbutus Biopharma Corporation (ABUS) Q2 2024 Earnings Call Transcript - Seeking Alpha